Please ensure Javascript is enabled for purposes of website accessibility

SEC Filing Details

Document Details

Form
Filing Date
Feb 13, 2024
Document Date
Feb 12, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Apellis Pharmaceuticals, Inc.
Issuer
APELLIS PHARMACEUTICALS, INC.
Filer
Francois Cedric